| Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs | Frank Vinluan | 09/02/20 | Seattle |
| Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs | Sarah de Crescenzo | 05/28/20 | Seattle |
| Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory | Frank Vinluan | 04/23/20 | Boston |
| Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More | Frank Vinluan | 01/31/20 | National |
| Daré to Add Microchip-Based Birth Control to Women’s Health Portfolio | Sarah de Crescenzo | 11/15/19 | San Diego |
| Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More | Frank Vinluan | 10/11/19 | San Francisco |
| Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs | Frank Vinluan | 09/03/19 | San Francisco |
| Gilead, Gates Foundation Join Lyndra’s $55M Funding for Phase 2 Tests | Frank Vinluan | 01/29/19 | Boston |
| 2019 Will See Progress on Personalization’s Last Frontier: Education | Bill Mortimore | 01/23/19 | Wisconsin |
| Forge Therapeutics Gets up to $11.1M to Advance “Superbug” Drugs | Sarah de Crescenzo | 01/03/19 | San Diego |
| Gates Foundation, Bristol-Myers Join $27M Funding for Vedanta Bio | Frank Vinluan | 12/24/18 | Boston |
| Pivot Bio Gets $70M, Led by Bill Gates’s Fund, to Replace Fertilizer | Frank Vinluan | 10/02/18 | San Francisco |
| Otsuka Ramps Up Its Antibody Game with $430M Visterra Acquisition | Frank Vinluan | 07/11/18 | Boston |
| Nanotech Liquidia Hops IPO Wave as Lead Drug Faces Late-Stage Test | Frank Vinluan | 06/29/18 | Raleigh Durham |
| What’s Hot in Seattle Biotech: Here’s the Agenda for the June 12 Event | Frank Vinluan | 05/21/18 | Seattle |
| Bill Gates on Saving Babies, Educating Kids, and Picking a Major | Gregory T. Huang | 04/27/18 | Boston |
| Gateses Pledge $15M for UW Computer Science Building Named for Them | Benjamin Romano | 12/13/17 | Seattle |
| Promega, Cellectar, Blockchain, & More: This Week’s WI Watchlist | Jeff Buchanan | 12/08/17 | Wisconsin |
| Scangos Heats Up Xconomy’s What’s Hot in Bay Area Biotech Lineup | Frank Vinluan | 11/02/17 | San Francisco |
| Arsanis Eyes IPO to Support Clinical Testing of Pneumonia Drug | Frank Vinluan | 10/23/17 | Boston |
| Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact | Frank Vinluan | 10/18/17 | Indiana |
| Vir Biotech Vies for Global Approach to Tackling Infectious Disease | Frank Vinluan | 10/18/17 | San Francisco |
| Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More | Alex Lash | 10/06/17 | National |
| Washington Faces Outward with Opening of Global Innovation Exchange | Benjamin Romano | 09/14/17 | Seattle |
| Civic Data Startup LiveStories, Estate App Tomorrow Ideas Raise Cash | Benjamin Romano | 07/19/17 | Seattle |
| Week in Review: Microsoft’s Introspective CEO on Trust in Tech | Benjamin Romano | 05/12/17 | Seattle |
| Seattle Week in Review: Amazon, Indy Bookstores, and Serendipity | Benjamin Romano | 04/28/17 | Seattle |
| How Battling New Epidemics Helps Fight Age-Old Killers | Mark Orr | 04/03/17 | Seattle |
| SutroVax Lands $64M From Roche, Others to Back Vaccine Studies | Frank Vinluan | 03/21/17 | San Francisco |
| Non-Profit Aims For Market Transparency In K-12 Edtech Purchases | Bernadette Tansey | 01/30/17 | San Francisco |
